Chronic Myeloid Leukemia‎

American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends

By

Rachel Narozniak, MA

Publish Date February 4, 2021

The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.

Iclusig Approved for Resistant or Intolerant Chronic-Phase CML

By

Brian Park, PharmD

Publish Date December 25, 2020

The sNDA approval is based on efficacy and safety data from the open-label phase 2 OPTIC trial and 5-year data from the phase 2 PACE trial.

AI-Based Model Made Optimal Selections of Frontline TKI Therapy in CML

By

Susan Moench, PhD, PA-C

Publish Date December 9, 2020

Investigators report on outcomes for patients with chronic phase CML whose treatment was determined using an artificial intelligence-based model.

British Society for Haematology Guideline Update for the Diagnosis and Management of Chronic Myeloid Leukemia

By

Caleb Rans

Publish Date October 23, 2020

The British Society for Haematology has published updated guidelines for the diagnosis and management of chronic myeloid leukemia in adults and children.

First-line Therapy Response vs Switching Treatments in Chronic Myeloid Leukemia

By

Patricia Chaney

Publish Date October 20, 2020

CP-CML patients who remain on first-line TKI therapy have better clinical responses than patients who switch within the first 3 years.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .